Scarica l'app Stockscreener
10.08
2.54%
0.25
Dopo l'orario di chiusura:
10.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$9.83
Aprire:
$9.86
Volume 24 ore:
38,330
Relative Volume:
0.93
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+4.46%
1M Prestazione:
-6.67%
6M Prestazione:
-6.93%
1 anno Prestazione:
-3.58%
Intervallo 1D:
$9.81
$10.09
Intervallo di 1 settimana:
$9.52
$10.09
Portata 52W:
$9.52
$12.53
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Nome
Global X Genomics Biotechnology Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta GNOM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| GNOM | 10.08 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Borsa (GNOM) Ultime notizie
When (GNOM) Moves Investors should Listen - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Newport Capital Group LLC Acquires Shares of 21,305 iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) - Defense World
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Top Canadian Genetics Stocks of 2024 - The Motley Fool Canada
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
(GNOM) Proactive Strategies - Stock Traders Daily
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Time for Healthcare ETFs? - Yahoo Finance
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
7 Best Biotech ETFs to Buy Now | Investing - U.S News & World Report Money
The Next Big Theme: June 2024 - Global X
How To Trade (GNOM) - Stock Traders Daily
Top Sector ETFs From Wall Street's Best Week in 3 Months - Yahoo New Zealand News
Why this money manager is shoring up cash and buying into commodities, genomics and Mexico - The Globe and Mail
5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network
When the Price of (GNOM) Talks, People Listen - Stock Traders Daily
Where are the Opportunities in (GNOM) - Stock Traders Daily
Private Advisor Group LLC Lowers Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Beyond Ordinary Model Portfolios - Global X
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 69.1% - Defense World
Profit from the Genomics Market Momentum With These ETFs - Yahoo Movies UK
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - InvestorPlace
Genomics ETF (GNOM) Hits New 52-Week High - Yahoo Lifestyle UK
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
(GNOM) Technical Data - Stock Traders Daily
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
9 Best Biotech ETFs for 2024 - GOBankingRates
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
Genomics and the Future of Healthcare Diagnostics – Global X ETFs - Global X
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Biotech Funds Underperform the Broader Market - Trackinsight
Video: Give Someone a Fish, You Feed Them—Unlock the Fish - CSRwire.com
Gene Therapy: A Cure for Cancer? - Opto RoW
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 ... - Nature.com
The Next Big Theme: February 2024 – Global X ETFs - Global X
Genomic data in the All of Us Research Program - Nature.com
3 Gene Editing Stocks With Unprecedented Surge Potential - Yahoo Finance
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
Two industries where Einstein would invest - Finimize
Global X Genomics Biotechnology Etf Azioni (GNOM) Dati Finanziari
Non sono disponibili dati finanziari per Global X Genomics Biotechnology Etf (GNOM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):